In any stage of life, the skin on your face is vulnerable to multiple influences. From the sun and pollution to hormones and stress levels, many factors can fade your natural glow.1
When it comes to refreshed, glowing and healthy-looking skin, facials and creams can only get us so far. You may notice your skin is looking dull, that a few fine lines and wrinkles are popping up, or there may be scarring from acne or age spots. Whatever the reason your skin may not be looking its best, Restylane® Skinboosters™ can help.2-13,25-26
.png)
Lasting deep hydration
Clinically proven to improve skin glow and boost facial skin quality.2,10
Skin surface evenness
Reduce the appearance of enlarged facial pores to improve skin surface evenness.9-11
Skin smoothness
Experience smooth facial skin with reduced roughness and enhanced skin texture.4
Skin tone evenness
Achieve measurable skin tone correction and a brighter skin tone.8,11
Reduced fine lines & wrinkles
Correct and smoothen fine lines and wrinkles and improve elasticity.4,6,9
Reduced scarring
100% of patients experience improved acne scarring and skin quality2
.png)
.png)
.png)
Restylane® SKINBOOSTERS™ restores a fresh and natural glow from within with fast-acting, immediate, deep and long-lasting hydration.2,8,9 Whether you are experiencing dry, crepey skin, fine lines and wrinkles, or maybe even acne scarring, the non-stabilized hyaluronic acid in Restylane® SKINBOOSTERS™ improves the natural skin structure and hydro-balance to give your face a smooth, youthful appearance.2,3,7,8,12,16
Restylane® SKINBOOSTERS™ can be applied to the mid- or lower-face areas, or to the entire face in one treatment cycle that can last for over a year.8 However, restoring the skin’s youthful composition should always be approached with the guidance and application of a certified professional. Here are the steps you can expect in your journey:
1.Consult a healthcare practitioner to determine the best treatment plan for you.
Your treatment plan will start with 1–3 sessions, spaced 4 weeks apart, to achieve optimal results.14,15
2.Receive your first treatment with minimal downtime.
After treatment, you may notice some slight redness, swelling, itching or tenderness at the injection site, but these reactions are generally mild to moderate and get better within a few days.14,15
3.Enjoy your refreshed and glowing skin.
A re-boosting treatment is recommended every 8-12 months, depending on your individual preferences and needs.17
.png)
.png)
References
1. Vleggaar D and Fitzgerald R. J Drugs Dermatol 2008; 7: 209-220. 2. Wu Y et al. J Cosmet Dermatol 2020; 19(7): 1627–1635. 3. Williams S et al. J Cosmet Dermatol. 2009;8(3):216–225.4. Ribé A et al. J Cosmet Laser Ther. 2011;13(4):154–161. 5. Lee BM et al. Arch Plast Surg. 2015;42(3):282–287. 6. Lim H-K et al. J Cosmet Laser Ther. 2014;16(1):32–36. 7. Qian W et al. J Cosmet Dermatol. 2018;17(4):596–599. 8. Kim J. Arch Aesthetic Plast Surg. 2014;20(2):97–103. 9. Gubanova EI et al. Poster presented at IMCAS, Jan–Feb 2015, Paris, France. 10. Gubanova EI et al. J Drugs Dermatol. 2015;14(3):288–299. 11. Kerscher M et al. Dermatol Surg. 2008;34(5):720–726. 12. Dierickx C et al. Dermatol Surg. 2018;44 Suppl 1:S10–S18. 13. Gubanova EI et al. Aesthetic Med. 2010;1:94–98. 14. Belmontesi M et al. J Drugs Dermatol. 2018;17(1):83–88. 15. Data on File. MA-54615. Restylane SKINBOOSTERS Competitor Comparison. Benching document 2022. 16. Edsman K et al. J Dermatol Surg 2012; 38(7 Pt 2): 1170-1179. 17. Nikolis A et al. Clin Cosmet Investig Dermatol. 2018;11:467–475. 18. Distante F et al. Dermatol Surg. 2009;35 Suppl 1:389–393. 19. Nikolis A, Enright KM. J Dermatol Skin Sci. 2020;2(1):26–28. 20. Restylane® Skinboosters™ VITAL EU IFU. 21. Restylane® Skinboosters™ VITAL LIGHT EU IFU. 22. Data on File. MA-47866. Restylane® 25 years publications listing. 23. Data on File. MA-48087. Restylane® 25 years publication analysis part II. 24. RESTYLANE VITAL approved in Europe. Available at: https://globenewswire.com/en/news-release/2004/05/27/311074/1036/en/RESTYLANE-VITAL-approved-in-Europe.html (accessed December 2022). 25. Data on File. MA-39929. Global 8 million treatments 2022.
.png)
